INCONTESTABLE® Blog
April 19, 2024
Webinar
Advertising Self-Regulation in 2024: Q&A with NAD Vice President Laura Brett
January 30, 2024
Never miss an Insight.
Sign upArticles
Inter Partes Review in Generic Drug Litigation—Why the USPTO Should Exercise Its Discretion to Deny IPR Petitions in Appropriate Hatch-Waxman Act Disputes Inter Partes Review in Generic Drug Litigation—Why the USPTO Should Exercise Its Discretion to Deny IPR Petitions in Appropriate Hatch-Waxman Act Disputes
March 7, 2014
pharmaphorumEvent
ANDA Workshop: Strategies and Insights for Branded Pharmaceutical Companies ANDA Workshop: Strategies and Insights for Branded Pharmaceutical Companies
February 4, 2014
Boston
Event
ANDA Workshop: Strategies and Insights For Branded Pharmaceutical Companies ANDA Workshop: Strategies and Insights For Branded Pharmaceutical Companies
October 17, 2013
Palo Alto
Event
ANDA Workshop: Strategies and Insights For Branded Pharmaceutical Companies ANDA Workshop: Strategies and Insights For Branded Pharmaceutical Companies
October 15, 2013
La Jolla
Articles
Useful in the United States, But Not in Canada: Divergent Applications of the Statutory Utility Requirements Useful in the United States, But Not in Canada: Divergent Applications of the Statutory Utility Requirements
October 3, 2011
Bloomberg Law ReportsEvent
Ariad v. Lilly: What Are the Lessons? Ariad v. Lilly: What Are the Lessons?
April 6, 2010
Webinar
IP Updates
Case Update: Ariad Pharmaceuticals, Inc. v. Eli Lilly and Company Case Update: Ariad Pharmaceuticals, Inc. v. Eli Lilly and Company
March 22, 2010
Articles
Litigation of the Written Description Litigation of the Written Description
June 22-25, 2005
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.